David John Glover

Title: David John Glover: Innovator in Recombinant Protein Production

Introduction

David John Glover is a notable inventor based in West Drayton, GB. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of 2 patents to his name, Glover's work has the potential to impact various applications in medicine and research.

Latest Patents

Glover's latest patents focus on methods for producing recombinant proteins. The first patent provides a method for controlling the partitioning of a recombinant protein between the supernatant and the periplasm in E. coli host cell cultures. This method involves several steps, including providing an E. coli host cell culture, changing the growth rate of the cells, and inducing the expression of the recombinant protein. The process allows for the determination of the yield of recombinant protein in both the culture supernatant and the periplasm, enabling the selection of optimal growth conditions for primary recovery.

Career Highlights

Throughout his career, David John Glover has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with UCB Pharma, a global biopharmaceutical company. His expertise in recombinant protein production has been instrumental in advancing research and development in these fields.

Collaborations

Glover has collaborated with several professionals, including Mukesh Sehdev and Dominic Gambier Reeks. These collaborations have contributed to the successful development of his patented methods and have fostered innovation in the biotechnology industry.

Conclusion

David John Glover's contributions to the field of recombinant protein production highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing biotechnological methods that can benefit various applications.